A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

February 24, 2023

Study Completion Date

April 13, 2023

Conditions

N/A, as no Specific Medical Condition Will be Treated

Interventions

DRUG

IncobotulinumtoxinA

Intradermal injections using different delivery methods (conventional needle and microneedles)

Trial Locations (1)

Merz Investigational Site #0490385, Hamburg